BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 28455369)

  • 1. Complement C5aR1 Signaling Promotes Polarization and Proliferation of Embryonic Neural Progenitor Cells through PKCζ.
    Coulthard LG; Hawksworth OA; Li R; Balachandran A; Lee JD; Sepehrband F; Kurniawan N; Jeanes A; Simmons DG; Wolvetang E; Woodruff TM
    J Neurosci; 2017 May; 37(22):5395-5407. PubMed ID: 28455369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement C3a receptor modulates embryonic neural progenitor cell proliferation and cognitive performance.
    Coulthard LG; Hawksworth OA; Conroy J; Lee JD; Woodruff TM
    Mol Immunol; 2018 Sep; 101():176-181. PubMed ID: 30449309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement C5a Receptor 1 Exacerbates the Pathophysiology of
    Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta.
    Hernandez MX; Namiranian P; Nguyen E; Fonseca MI; Tenner AJ
    ASN Neuro; 2017 Feb; 9(1):1759091416687871. PubMed ID: 28078911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression.
    Carvalho K; Schartz ND; Balderrama-Gutierrez G; Liang HY; Chu SH; Selvan P; Gomez-Arboledas A; Petrisko TJ; Fonseca MI; Mortazavi A; Tenner AJ
    J Neuroinflammation; 2022 Jul; 19(1):178. PubMed ID: 35820938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.
    Nabizadeh JA; Manthey HD; Panagides N; Steyn FJ; Lee JD; Li XX; Akhir FNM; Chen W; Boyle GM; Taylor SM; Woodruff TM; Rolfe BE
    FASEB J; 2019 Oct; 33(10):11060-11071. PubMed ID: 31298935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin.
    Sadik CD; Miyabe Y; Sezin T; Luster AD
    Semin Immunol; 2018 Jun; 37():21-29. PubMed ID: 29602515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1.
    Shutov LP; Warwick CA; Shi X; Gnanasekaran A; Shepherd AJ; Mohapatra DP; Woodruff TM; Clark JD; Usachev YM
    J Neurosci; 2016 May; 36(18):5055-70. PubMed ID: 27147658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1
    Wang HA; Lee JD; Lee KM; Woodruff TM; Noakes PG
    Skelet Muscle; 2017 Jun; 7(1):10. PubMed ID: 28571586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
    Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
    FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C5a-C5aR1 Axis Activation Drives Envenomation Immunopathology by the Snake
    Silva de França F; Villas-Boas IM; Cogliati B; Woodruff TM; Reis EDS; Lambris JD; Tambourgi DV
    Front Immunol; 2021; 12():652242. PubMed ID: 33936074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease.
    Pandey MK; Burrow TA; Rani R; Martin LJ; Witte D; Setchell KD; Mckay MA; Magnusen AF; Zhang W; Liou B; Köhl J; Grabowski GA
    Nature; 2017 Mar; 543(7643):108-112. PubMed ID: 28225753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergen-Induced C5a/C5aR1 Axis Activation in Pulmonary CD11b
    Antoniou K; Ender F; Vollbrandt T; Laumonnier Y; Rathmann F; Pasare C; Singh H; Köhl J
    Cells; 2020 Jan; 9(2):. PubMed ID: 31991941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin.
    Russkamp NF; Ruemmler R; Roewe J; Moore BB; Ward PA; Bosmann M
    FASEB J; 2015 Sep; 29(9):3762-72. PubMed ID: 25999468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterisation of small molecule C5aR1 inhibitors in human cells reveals biased activities for signalling and function.
    Li XX; Lee JD; Massey NL; Guan C; Robertson AAB; Clark RJ; Woodruff TM
    Biochem Pharmacol; 2020 Oct; 180():114156. PubMed ID: 32682759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of activation and biased signaling in complement receptor C5aR1.
    Feng Y; Zhao C; Deng Y; Wang H; Ma L; Liu S; Tian X; Wang B; Bin Y; Chen P; Yan W; Fu P; Shao Z
    Cell Res; 2023 Apr; 33(4):312-324. PubMed ID: 36806352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory Syncytial Virus Exacerbates Kidney Damages in IgA Nephropathy Mice via the C5a-C5aR1 Axis Orchestrating Th17 Cell Responses.
    Hu X; Feng J; Zhou Q; Luo L; Meng T; Zhong Y; Tang W; Deng S; Li X
    Front Cell Infect Microbiol; 2019; 9():151. PubMed ID: 31134161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C5a/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia/reperfusion injury.
    Peng Q; Wu W; Wu KY; Cao B; Qiang C; Li K; Sacks SH; Zhou W
    Kidney Int; 2019 Jul; 96(1):117-128. PubMed ID: 31029505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.
    Hernandez MX; Jiang S; Cole TA; Chu SH; Fonseca MI; Fang MJ; Hohsfield LA; Torres MD; Green KN; Wetsel RA; Mortazavi A; Tenner AJ
    Mol Neurodegener; 2017 Sep; 12(1):66. PubMed ID: 28923083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients.
    Karasu E; Demmelmaier J; Kellermann S; Holzmann K; Köhl J; Schmidt CQ; Kalbitz M; Gebhard F; Huber-Lang MS; Halbgebauer R
    Front Immunol; 2020; 11():1789. PubMed ID: 32983087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.